BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11230633)

  • 21. Differential diagnosis of adrenal masses using out-of-phase FLASH imaging. A preliminary report.
    Tsushima Y; Ishizaka H; Kato T; Matsumoto M
    Acta Radiol; 1992 May; 33(3):262-5. PubMed ID: 1591131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
    Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
    J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging differentiation of adrenal masses at 1.5 T: T2-weighted images, chemical shift imaging, and Gd-DTPA dynamic studies.
    Słapa RZ; Jakubowski W; Dabrowska E; Januszewicz A; Tymińska B; Feltynowski T; Lapiński M; Fijuth J
    MAGMA; 1996; 4(3-4):163-79. PubMed ID: 9220405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T--preliminary results.
    Marin D; Soher BJ; Dale BM; Boll DT; Youngblood RS; Merkle EM
    Radiology; 2010 Jan; 254(1):179-87. PubMed ID: 20032151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
    Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. State-of-the-art MR imaging of the adrenal gland.
    Lee MJ; Mayo-Smith WW; Hahn PF; Goldberg MA; Boland GW; Saini S; Papanicolaou N
    Radiographics; 1994 Sep; 14(5):1015-29; discussion 1029-32. PubMed ID: 7991811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images.
    Ichikawa T; Ohtomo K; Uchiyama G; Koizumi K; Monzawa S; Oba H; Nogata Y; Kachi K; Toyama K; Yamaguchi M
    Radiology; 1994 Oct; 193(1):247-50. PubMed ID: 8090900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of adrenal masses using MR imaging with histopathologic correlation.
    Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
    AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion tensor imaging in the differentiation of adrenal adenomas and metastases.
    Işık Y; Gürses B; Taşdelen N; Kılıçkesmez O; Fırat Z; Ordu C; Gürmen N
    Diagn Interv Radiol; 2012; 18(2):189-94. PubMed ID: 21960162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
    Woo S; Cho JY; Kim SY; Kim SH
    Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Turbo-spin-echo (TSE) sequences with selective fat suppression (SPIR) compared with chemical shift sequences in MRI for differentiation of adrenal tumors. Spectral Presaturation by Inversion Recovery].
    Kreft B; Sommer T; Vahlensieck M; Seewald S; Vetter H; Schild H
    Rofo; 1995 Apr; 162(4):311-8. PubMed ID: 7749086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign adrenocortical masses: diagnosis with chemical shift MR imaging.
    Mitchell DG; Crovello M; Matteucci T; Petersen RO; Miettinen MM
    Radiology; 1992 Nov; 185(2):345-51. PubMed ID: 1410337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications.
    Adam SZ; Nikolaidis P; Horowitz JM; Gabriel H; Hammond NA; Patel T; Yaghmai V; Miller FH
    Radiographics; 2016; 36(2):414-32. PubMed ID: 26849154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR characterization of adrenal masses: field strength and pulse sequence considerations.
    Kier R; McCarthy S
    Radiology; 1989 Jun; 171(3):671-4. PubMed ID: 2717736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Versus Qualitative Methods in Evaluation of T2 Signal Intensity to Improve Accuracy in Diagnosis of Pheochromocytoma.
    Borhani AA; Hosseinzadeh K
    AJR Am J Roentgenol; 2015 Aug; 205(2):302-10. PubMed ID: 26204279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal gland: MR imaging.
    Chang A; Glazer HS; Lee JK; Ling D; Heiken JP
    Radiology; 1987 Apr; 163(1):123-8. PubMed ID: 3823423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging.
    Kim JK; Kim SH; Jang YJ; Ahn H; Kim CS; Park H; Lee JW; Kim S; Cho KS
    Radiology; 2006 Apr; 239(1):174-80. PubMed ID: 16507752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging.
    Outwater EK; Siegelman ES; Radecki PD; Piccoli CW; Mitchell DG
    AJR Am J Roentgenol; 1995 Sep; 165(3):579-83. PubMed ID: 7645474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.